Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Future Oncology (London, England)
|
March 12, 2021
Risk tolerance in adjuvant and metastatic melanoma settings: a patient perspective study using the threshold technique
Carol Mansfield, Kelley Myers, Kathleen Klein, et al.
Therapeutics and Clinical Risk Management
|
December 28, 2018
Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
Chi-Chang Chen, Pallavi B Rane, Dionne M Hines, et al.
Melanoma Research
|
December 22, 2022
Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients
Allison Betof Warner, Ahmad Tarhini, Barinder Kang, et al.
International Journal of Clinical Oncology
|
June 25, 2026
Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer
Neal Shore, Nguyen, Barinder Kang, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 8, 2017
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
Douglas Mapel, François Laliberté, Melissa H Roberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 21, 2024
Effectiveness and Safety of Retreatment with <sup>177</sup>Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States
Ebrahim S Delpassand, Soheil M Yazdi, Shashank Ghantoji, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Future Oncology (London, England)
|
March 12, 2021
Risk tolerance in adjuvant and metastatic melanoma settings: a patient perspective study using the threshold technique
Carol Mansfield, Kelley Myers, Kathleen Klein, et al.
Therapeutics and Clinical Risk Management
|
December 28, 2018
Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
Chi-Chang Chen, Pallavi B Rane, Dionne M Hines, et al.
Melanoma Research
|
December 22, 2022
Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients
Allison Betof Warner, Ahmad Tarhini, Barinder Kang, et al.
International Journal of Clinical Oncology
|
June 25, 2026
Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer
Neal Shore, Nguyen, Barinder Kang, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 8, 2017
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
Douglas Mapel, François Laliberté, Melissa H Roberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 21, 2024
Effectiveness and Safety of Retreatment with <sup>177</sup>Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States
Ebrahim S Delpassand, Soheil M Yazdi, Shashank Ghantoji, et al.
Page
of 2